According to Microbot Medical 's latest financial reports the company's current EPS (TTM) is -$1.48. In 2022 the company made an earnings per share (EPS) of -$1.81 a decrease over its 2021 EPS that were of -$1.59.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.48 | -18.23% |
2022 | -$1.81 | 13.84% |
2021 | -$1.59 | 23.26% |
2020 | -$1.29 | -24.56% |
2019 | -$1.71 | -28.15% |
2018 | -$2.38 | -18.21% |
2017 | -$2.91 | -58.01% |
2016 | -$6.93 | -98.91% |
2015 | -$637.11 | -28.49% |
2014 | -$891.00 | -11.29% |
2013 | -$1,004 | -35.42% |
2012 | -$1,555 | -35.14% |
2011 | -$2,398 | -27.45% |
2010 | -$3,305 | -21.54% |
2009 | -$4,212 | -23.53% |
2008 | -$5,508 | 9.68% |
2007 | -$5,022 | 29.17% |
2006 | -$3,888 | 33.33% |
2005 | -$2,916 | -41.94% |
2004 | -$5,022 | -32.61% |
2003 | -$7,452 | 0% |
2002 | -$7,452 | 109.09% |
2001 | -$3,564 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$0.06000 | -95.95% | Bahamas |
NRC Health
NRC | $1.19 | -180.41% | ๐บ๐ธ USA |